These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3163828)

  • 21. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
    Ritz E; Stein G
    Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
    Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.
    Swales P; Williams B
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):79-89. PubMed ID: 12228847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
    Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
    Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal vascular effects of calcium channel blockers in hypertension.
    Benstein JA; Dworkin LD
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):305S-312S. PubMed ID: 2078317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Felodipine in the treatment of severe refractory hypertension.
    Nussinovitch N; Carroll J; Shamiss A; Grossman E; Katz A; Rachima C; Rosenthal T
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S165-7. PubMed ID: 8872852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Felodipine as monotherapy and associated with enalapril for essential hypertension.
    Navarro JF; García-Pérez J; Rodríguez-Pérez JC
    Am J Cardiol; 1997 Sep; 80(5):683-4. PubMed ID: 9295013
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
    Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure].
    Ritz E; Mann JF; Rambausek M
    Z Kardiol; 1988; 77 Suppl 3():57-60. PubMed ID: 2850688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.